Table 2 Different clinical and laboratory parameters before and after iron therapy.
| Â | Obese children with IDA | Non-obese children with IDA | P value |
|---|---|---|---|
| Â | (n = 35) | (n = 35) | Â |
BMI (kg/m2) | Â | Â | Â |
Baseline | 25.70 ± 2.2 | 16.30 ± 1.9 | <0.01 |
3 months after Fe therapy | 25.91 ± 2.3 | 16.22 ± 1.2 | <0.01 |
   p value | >0.05 | >0.05 |  |
Hb (g/dl) | Â | Â | Â |
Baseline | 8.82 ± 1.2 | 8.22 ± 1.4 | >0.05 |
3 months after Fe therapy | 10.1 ± 0.8 | 12.8 ± 0.7 | <0.05 |
   p value | <0.05 | <0.05 |  |
Serum iron (ug/dl) | Â | Â | Â |
Baseline | 28.83 ± 2.5 | 29.28 ± 4.6 | >0.05 |
3 months after Fe therapy | 44.6 ± 6.9 | 65 ± 8.9 | <0.05 |
   p value | <0.05 | <0.05 |  |
TIBC (mg/dl) | Â | Â | Â |
Baseline | 491 ± 24 | 478 ± 15 | >0.05 |
3 months after Fe therapy | 385 ± 42 | 210 ± 23 | <0.05 |
   p value | <0.05 | <0.05 |  |
Serum ferritin (ng/ml) | Â | Â | Â |
Baseline | 51.91 ± 8.7 | 7.52 ± 1.6 | <0.01 |
3 months after Fe therapy | 52.19 ± 4.1 | 54.19 ± 4.1 | >0.05 |
   p value | >0.05 | <0.01 |  |
Serum hepcidin (nmol/L) | Â | Â | Â |
Baseline | 4.96 ± 1.2 | 0.11 ± 0.03 | <0.01 |
3 months after Fe therapy | 4.56 ± 1.4 | 1.62 ± 0.6 | <0.01 |
   p value | >0.05 | <0.01 |  |